FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma

被引:0
|
作者
I. Tsimafeyeu
A. Khasanova
E. Stepanova
M. Gordiev
D. Khochenkov
A. Naumova
I. Varlamov
A. Snegovoy
L. Demidov
机构
[1] Kidney Cancer Research Bureau,
[2] Tatarstan Regional Cancer Center,undefined
[3] N.N. Blokhin Russian Cancer Research Center,undefined
[4] Altai Regional Cancer Center,undefined
来源
关键词
FGFR2; Overexpression; Mutations; Papillary renal cell carcinoma; Overall survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:265 / 268
页数:3
相关论文
共 50 条
  • [31] Checkpoint inhibitors in metastatic papillary renal cell carcinoma
    de Vries-Brilland, M.
    McDermott, D. F.
    Suarez, C.
    Powles, T.
    Gross-Goupil, M.
    Ravaud, A.
    Flippot, R.
    Escudier, B.
    Albiges, L.
    CANCER TREATMENT REVIEWS, 2021, 99
  • [32] Bevacizumab in metastatic papillary renal cell carcinoma (PRCC).
    Irshad, T.
    Olencki, T.
    Zynger, D. L.
    Coston, A.
    Mortazavi, A.
    Monk, J. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Characterizing the outcomes of metastatic papillary renal cell carcinoma
    Wells, John Connor
    Donskov, Frede
    Fraccon, Anna P.
    Pasini, Felice
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Knox, Jennifer J.
    Rha, Sun Young
    Agarwal, Neeraj
    Bowman, Isaac Alex
    Lee, Jae-Lyun
    Pal, Sumanta K.
    Srinivas, Sandy
    Ernst, Douglas Scott
    Vaishampayan, Ulka N.
    Wood, Lori A.
    Simpson, Robin
    De Velasco, Guillermo
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    CANCER MEDICINE, 2017, 6 (05): : 902 - 909
  • [34] A signature of three miRNAs predicts survival in renal papillary cell carcinoma using bioinformatics methods
    Li, Yongheng
    Zheng, Jie
    Xue, Xiaoru
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (02): : 1129 - 1139
  • [35] The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma
    Steiner, Thomas
    Kirchner, Hartmut
    Siebels, Michael
    Doehn, Christian
    Heynemann, Hans
    Varga, Zoltan
    Rohde, Detlef
    Schubert, Joerg
    Jocham, Dieter
    Stief, Christian
    Fornara, Paolo
    Hofmann, Rainer
    Loening, Stefan
    Roigas, Jan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (06) : 905 - 910
  • [36] The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma
    Thomas Steiner
    Hartmut Kirchner
    Michael Siebels
    Christian Doehn
    Hans Heynemann
    Zoltan Varga
    Detlef Rohde
    Joerg Schubert
    Dieter Jocham
    Christian Stief
    Paolo Fornara
    Rainer Hofmann
    Stefan Loening
    Jan Roigas
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 905 - 910
  • [37] Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
    Buda-Nowak, Anna
    Kucharz, Jakub
    Dumnicka, Paulina
    Kuzniewski, Marek
    Herman, Roman Maria
    Zygulska, Aneta L.
    Kusnierz-Cabala, Beata
    MEDICAL ONCOLOGY, 2017, 34 (04)
  • [38] Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
    Anna Buda-Nowak
    Jakub Kucharz
    Paulina Dumnicka
    Marek Kuzniewski
    Roman Maria Herman
    Aneta L. Zygulska
    Beata Kusnierz-Cabala
    Medical Oncology, 2017, 34
  • [39] Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma
    Kucharz, Jakub
    Giza, Agnieszka
    Dumnicka, Paulina
    Kuzniewski, Marek
    Kusnierz-Cabala, Beata
    Bryniarski, Pawel
    Herman, Roma
    Zygulska, Aneta Lidia
    Krzemieniecki, Krzysztof
    MEDICAL ONCOLOGY, 2016, 33 (10)
  • [40] Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma
    Jakub Kucharz
    Agnieszka Giza
    Paulina Dumnicka
    Marek Kuzniewski
    Beata Kusnierz-Cabala
    Pawel Bryniarski
    Roma Herman
    Aneta Lidia Zygulska
    Krzysztof Krzemieniecki
    Medical Oncology, 2016, 33